Bst2/tetherin is induced in neurons by type I interferon and viral infection but is dispensable for protection against neurotropic viral challenge

Journal of Virology

Volumn 89, Issue 21, 2015, Pages 11011-11018

  Holmgren, Alicia M ^a,b   Miller, Katelyn D ^b,c   Cavanaugh, Sarah E ^a,b   Rall, Glenn F ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BST2 PROTEIN; INTERFERON; MEMBRANE PROTEIN; RNA; STAT1 PROTEIN; UNCLASSIFIED DRUG; BST2 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; BST2 GENE; CELL PROTECTION; CELLS BY BODY ANATOMY; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE; GENE DELETION; GENE FUNCTION; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS RELEASE; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; IMMUNOLOGY; MEASLES; METABOLISM; NERVE CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, VIRAL; HIPPOCAMPUS; INTERFERON TYPE I; MEASLES; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MICE; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84945207996     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01745-15     Document Type: Article

References (47)

1. Goodbourn S, Didcock L, Randall RE. 2000. Interferons: cell signalling, immune modulation, antiviral responses and virus countermea- sures. J Gen Virol 81:2341-2364. http://dx.doi.org/10.1099/0022-1317 -81-10-2341.
2. Sorgeloos F, Kreit M, Hermant P, Lardinois C, Michiels T. 2013. Antiviral type I and type III interferon responses in the central nervous system. Viruses 5:834-857. http://dx.doi.org/10.3390/v5030834.
3. Snell LM, Brooks DG. 2015. New insights into type I interferon and the immunopathogenesis of persistent viral infections. Curr Opin Immunol 34:91-98. http://dx.doi.org/10.1016/j.coi.2015.03.002.
4. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M. 2006. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 177:3260-3265. http://dx .doi.org/10.4049/jimmunol.177.5.3260.
5. Goto T, Kennel SJ, Abe M, Takishita M, Kosaka M, Solomon A, Saito S. 1994. A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 84:1922-1930.
6. Neil SJD, Zang T, Bieniasz PD. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430. http://dx.doi.org /10.1038/nature06553.
7. Fitzpatrick K, Skasko M, Deerinck TJ, Crum J, Ellisman MH, Guatelli J. 2010. Direct restriction of virus release and incorporation of the interferon- induced protein BST-2 into HIV-1 particles. PLoS Pathog 6(3): e1000701. http://dx.doi.org/10.1371/journal.ppat.1000701.
8. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, Bieniasz PD. 2009. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139:499-511. http://dx.doi.org/10 .1016/j.cell.2009.08.039.
9. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. 2008. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3:245-252. http://dx.doi.org /10.1016/j.chom.2008.03.001.
10. Hammonds J, Wang J-J, Yi H, Spearman P. 2010. Immunoelectron microscopic evidence for tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog 6(2):e1000749. http://dx.doi.org/10.1371/journal.ppat.1000749.
11. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. 2009. Tetherinmediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A 106:2886-2891. http://dx.doi.org/10 .1073/pnas.0811014106.
12. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, Guo JT. 2010. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84: 12646-12657. http://dx.doi.org/10.1128/JVI.01328-10.
13. Liu Y, Luo S, He S, Zhang M, Wang P, Li C, Huang W, Hu B, Griffin GE, Shattock RJ. 2015. Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins. Virology 475:96-109. http://dx.doi .org/10.1016/j.virol.2014.11.005.
14. Hotter D, Sauter D, Kirchhoff F. 2013. Emerging role of the host restriction factor tetherin in viral immune sensing. J Mol Biol 425:4956-4964. http://dx.doi.org/10.1016/j.jmb.2013.09.029.
15. Martin-Serrano J, Neil SJD. 2011. Host factors involved in retroviral budding and release. Nat Rev Microbiol 9:519-531. http://dx.doi.org/10 .1038/nrmicro2596.
16. Evans DT, Serra-Moreno R, Singh RK, Guatelli JC. 2010. BST-2/ tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol 18:388-396. http://dx.doi.org/10.1016/j.tim .2010.06.010.
17. Cocka LJ, Bates P. 2012. Identification of alternatively translated tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog 8(9):e1002931. http://dx.doi.org/10.1371/journal.ppat.1002931.
18. Jia X, Weber E, Tokarev A, Lewinski M, Rizk M, Suarez M, Guatelli J, Xiong Y. 2014. Transmembrane helices are represented by cylinders and the Nef myristoyl anchor is represented by a cyan sphere. Elife 3:1-24. http://dx.doi.org/10.7554/eLife.02362.
19. Serra-Moreno R, Zimmermann K, Stern LJ, Evans DT. 2013. Tetherin/ BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis. PLoS Pathog 9(7):e1003487. http://dx.doi.org/10.1371/journal.ppat.1003487.
20. Masuyama N, Kuronita T, Tanaka R, et al. 2009. HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with adaptin. J Biol Chem 284:15927-15941. http://dx.doi.org/10.1074 /jbc.M109.005124.
21. Sarojini S, Theofanis T, Reiss CS. 2011. Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons. DNA Cell Biol 30: 965-974. http://dx.doi.org/10.1089/dna.2011.1384.
22. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Diamond MS. 2013. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med 19:458-464. http://dx.doi.org/10.1038/nm.3108.
23. O'Donnell LA, Conway S, Rose RW, Nicolas E, Slifker M, Balachandran S, Rall GF. 2012. STAT1-independent control of a neurotropic measles virus challenge in primary neurons and infected mice. J Immunol 188: 1915-1923. http://dx.doi.org/10.4049/jimmunol.1101356.
24. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin- Combe C, Gerlier D. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025-6032.
25. Dörig RE, Marcil A, Chopra A, Richardson CD. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295- 305. http://dx.doi.org/10.1016/0092-8674(93)80071-L.
26. Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, Oldstone MBA. 1997. A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci U S A 94:4659-4663. http://dx.doi.org/10 .1073/pnas.94.9.4659.
27. Makhortova NR, Askovich P, Patterson CE, Gechman LA, Gerard NP, Rall GF. 2007. Neurokinin-1 enables measles virus trans-synaptic spread in neurons. Virology 362:235-244. http://dx.doi.org/10.1016/j.virol.2007 .02.033.
28. Lawrence DMP, Patterson CE, Gales TL, D'Orazio JL, Vaughn MM, Rall GF. 2000. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J Virol 74:1908-1918. http://dx.doi.org/10.1128/JVI.74.4.1908 -1918.2000.
29. Lawrence DMP, Vaughn MM, Belman AR, Cole JS, Rall GF. 1999. Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J Virol 73:1795-1801.
30. Patterson CE, Lawrence DMP, Echols LA, Rall GF. 2002. Immunemediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 76:4497- 4506. http://dx.doi.org/10.1128/JVI.76.9.4497-4506.2002.
31. Rose RW, Vorobyeva AG, Skipworth JD, Nicolas E, Rall GF. 2007. Altered levels of STAT1 and STAT3 influence the neuronal response to interferon gamma. J Neuroimmunol 192:145-156. http://dx.doi.org/10 .1016/j.jneuroim.2007.10.007.
32. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
33. Delhaye S, Paul S, Blackqori G, Minet M, Weber F, Staeheli P, Michiels T. 2006. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 103:7835-7840. http://dx.doi.org/10.1073/pnas .0602460103.
34. Cavanaugh SE, Holmgren AM, Rall GF. 2015. Homeostatic interferon expression in neurons is sufficient for early control of viral infection. J Neuroimmunol 279:11-19. http://dx.doi.org/10.1016/j.jneuroim.2014.12 .012.
35. Tishon A, Lewicki H, Andaya A, McGavern D, Martin L, Oldstone MBA. 2006. CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with eitherCD8T cells or with B cells: CD4, CD8 or B cells alone are ineffective. Virology 347: 234-245. http://dx.doi.org/10.1016/j.virol.2006.01.050.
36. Podolsky MA, Solomos AC, Durso LC, Evans SM, Rall GF, Rose RW. 2012. Extended JAK activation and delayed STAT1 dephosphorylation contribute to the distinct signaling profile of CNS neurons exposed to interferon-gamma. J Neuroimmunol 251:33-38. http://dx.doi.org/10 .1016/j.jneuroim.2012.06.006.
37. Viswanathan K, Smith MS, Malouli D, Mansouri M, Nelson JA, Früh K. 2011. BST2/tetherin enhances entry of human cytomegalovirus. PLoS Pathog 7(11):e1002332. http://dx.doi.org/10.1371/journal.ppat.1002332.
38. Swiecki M, Wang Y, Gilfillan S, Lenschow DJ, Colonna M. 2012. Cutting edge: paradoxical roles of BST2/tetherin in promoting type I IFN response and viral infection. J Immunol 188:2488-2492. http://dx.doi.org /10.4049/jimmunol.1103145.
39. Rollason R, Korolchuk V, Hamilton C, Jepson M, Banting G. 2009. A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. J Cell Biol 184:721-736. http://dx.doi.org/10.1083/jcb.200804154.
40. Burdeinick-Kerr R, Govindarajan D, Griffin DE. 2009. Noncytolytic clearance of Sindbis virus infection from neurons by gamma interferon is dependent on Jak/Stat signaling. J Virol 83:3429-3435. http://dx.doi.org /10.1128/JVI.02381-08.
41. Griffin DE. 2010. Recovery from viral encephalomyelitis: immunemediated noncytolytic virus clearance from neurons. Immunol Res 47: 123-133. http://dx.doi.org/10.1007/s12026-009-8143-4.
42. Patterson CE, Daley JK, Rall GF. 2002. Neuronal survival strategies in the face of RNA viral infection. J Infect Dis 186:215-219.
43. Griffin DE, Metcalf T. 2011. Clearance of virus infection from the CNS. Curr Opin Virol 1:216-221. http://dx.doi.org/10.1016/j.coviro.2011.05 .021.
44. St Leger AJ, Hendricks RL. 2011. CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation. J Neurovirol 17:528- 534. http://dx.doi.org/10.1007/s13365-011-0062-1.
45. Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL. 2000. CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191:1459-1466. http://dx.doi.org/10.1084 /jem.191.9.1459.
46. Wakim LM, Woodward-Davis A, Liu R, et al. 2012. The molecular signature of tissue resident memory CD8 T cells isolated from the brain. J Immunol 189:3462-3471. http://dx.doi.org/10.4049/jimmunol.1201305.
47. Wakim LM, Woodward-Davis A, Bevan MJ. 2010. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci U S A 107:17872- 17879. http://dx.doi.org/10.1073/pnas.1010201107.